Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

ABBOTT IRELAND

US

Last updated May 24, 2026

What ABBOTT IRELAND makes

The company manufactures in vitro diagnostic (IVD) kits and systems for measuring thyroid hormones—including free thyroxine (FT4), total thyroxine (TT4), total triiodothyronine (TT3), free triiodothyronine (FT3), and thyroid stimulating hormone (TSH)—using chemiluminescent immunoassay technology. It also produces kits for albumin, progesterone, and total aspartate aminotransferase (AST) assays, primarily using spectrophotometry. These products are designed for laboratory use in automated platforms like ARCHITECT and Alinity.

The diagnostic kits fall under FDA device classes I and II, with regulatory submissions including 510(k) clearances and Unique Device Identifier (UDI) listings. The company’s products are authorised for use in the United States, where the manufacturer is based.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Abbott Ireland manufacture?

Abbott Ireland manufactures in vitro diagnostic (IVD) kits and automated systems for laboratory testing. These include chemiluminescent immunoassay kits for thyroid hormones—such as free thyroxine (FT4), total thyroxine (TT4), total triiodothyronine (TT3), free triiodothyronine (FT3), and thyroid stimulating hormone (TSH)—as well as spectrophotometry-based kits for albumin, progesterone, and total aspartate aminotransferase (AST). The devices are designed for use in automated platforms like ARCHITECT and Alinity.

Where is Abbott Ireland based, and what is its primary market focus?

Abbott Ireland is based in the United States. Its primary focus is on developing and manufacturing in vitro diagnostic (IVD) devices authorised for use in the U.S. market. The company specialises in thyroid hormone assays and other laboratory tests, catering to clinical and diagnostic needs in healthcare settings.

Which regulatory registries list Abbott Ireland’s devices?

Abbott Ireland’s devices are listed in the FDA’s 510(k) clearance registry and the Unique Device Identifier (UDI) database. These registries document regulatory submissions and authorisations required for IVD devices in the United States, ensuring compliance with FDA requirements.

How are Abbott Ireland’s devices classified under FDA regulations?

Abbott Ireland’s IVD devices fall under FDA device classes I and II. Class I devices generally pose minimal risk and may require less stringent regulatory oversight, while Class II devices involve moderate risk and require special controls to ensure safety and effectiveness. The classification is determined based on the device’s intended use and potential health impact.

What technologies are used in Abbott Ireland’s diagnostic kits?

Abbott Ireland’s diagnostic kits primarily utilise chemiluminescent immunoassay technology for thyroid hormone assays (e.g., FT4, TT4, FT3, TT3, TSH) and spectrophotometry for tests like albumin, progesterone, and AST. These technologies enable precise and automated measurements in clinical laboratory settings, improving diagnostic accuracy and efficiency.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
Website
xx.xx
LinkedIn
—
Facebook
—
Phone
+1(877)422-2688
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
989964119

Catalogue (240)

Page 1 of 5
DeviceModel / ReferenceRegistriesClassStatus
Architect 07K6437
FDA UDI
Class IIActive
Architect 07K6332
FDA UDI
Class IIActive
Alinity 07P4830
FDA UDI
Class IIActive
Alinity 04Z2135
FDA UDI
Class IIActive
Architect 7K66-32
FDA UDI
Class IIActive
Alinity 07P6501
FDA UDI
Class IIActive
Architect 08G6624
FDA UDI
Class IIActive
Alinity 08P3601
FDA UDI
Class IIActive
Architect 04S8820
FDA UDI
Class IActive
Architect 08L9144
FDA UDI
Class IIActive
Architect 5P02-02
FDA UDI
Class IIActive
Alinity 07P6702
FDA UDI
Class IIActive
Alinity 07P4820
FDA UDI
Class IIActive
Alinity 07P7030
FDA UDI
Class IIActive
Alinity 09P6224
FDA UDI
Class IIActive
Architect 7K65-39
FDA UDI
Class IIActive
Alinity 04T8830
FDA UDI
Class IActive
Architect 7K63-35
FDA UDI
Class IIActive
Architect 7K63-10
FDA UDI
Class IIActive
Alinity 07P5131
FDA UDI
Class IIActive
Architect 04T1330
FDA UDI
Class IActive
Alinity 04Z2110
FDA UDI
Class IActive
Alinity 07P5010
FDA UDI
Class IActive
Architect 04U4530
FDA UDI
Class IIActive
Architect 7K65-10
FDA UDI
Class IActive
Alinity 04T8420
FDA UDI
Class IActive
Alinity 08P4501
FDA UDI
Class IIActive
Alinity 04Z2101
FDA UDI
Class IIActive
Alinity 09P5624
FDA UDI
Class IIActive
Alinity 07P6712
FDA UDI
Class IActive
Alinity 07P6630
FDA UDI
Class IActive
Architect 7K62-25
FDA UDI
Class IActive
Architect 1P74-02
FDA UDI
Class IActive
Alinity 07P9401
FDA UDI
Class IIActive
Architect 04T3420
FDA UDI
Class IIActive
Architect 04T0220
FDA UDI
Class IActive
Architect 7K72-10
FDA UDI
Class IActive
Alinity 04T8220
FDA UDI
Class IIActive
Architect 7K65-27
FDA UDI
Class IActive
Architect 7K72-35
FDA UDI
Class IActive
Architect 7K64-50
FDA UDI
Class IIActive
Architect 07K6327
FDA UDI
Class IIActive
Architect 7K64-25
FDA UDI
Class IIActive
Architect 7K75-25
FDA UDI
Class IActive
Alinity 07P4920
FDA UDI
Class IActive
Architect 7K64-01
FDA UDI
Class IIActive
Alinity 04U3030
FDA UDI
Class IIActive
Architect 7K61-27
FDA UDI
Class IIActive
Architect 7K61-12
FDA UDI
Class IIActive
Architect 7K76-10
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Establishments (1)

Establishments registered with the FDA under this company group, matched by name.

  • Abbott Ireland SLIGO · IE FEI 3008344661